Literature DB >> 31487530

TRAF6 promotes the progression and growth of colorectal cancer through nuclear shuttle regulation NF-kB/c-jun signaling pathway.

Guangwei Zhu1, Zhibin Cheng1, Yongjian Huang2, Wei Zheng2, Shugang Yang2, Chunlin Lin2, Jianxin Ye1.   

Abstract

AIMS: TRAF6 is an intracellular signal adapter molecule plays a significant role in tumor development. However, the specific mechanism causes and promotes of colorectal cancer keep largely unknown. Therefore, we sought to investigate the roles and the molecular mechanisms of TRAF6 in regulation colorectal cancer.
MATERIAL AND METHODS: The immunohistochemistry analyzed the expression of TRAF6 in colorectal cancer samples and analyzed the effects of expression of TRAF6 on the prognosis in colorectal cancer. The roles of TRAF6 in regulating colorectal cancer cell proliferation, colony formation, cell migration, cell wound healing and cell invasion were evaluated in vitro. Animal studies were performed to investigate the effects of TRAF6 on tumor growth. mRNA abundance of key genes was analyzed via qPCR. Protein level of TRAF6 and NF-κB/AP-1 signaling pathways was examined by Western blot. Luciferase reporter and Immunofluorescence assays were used to identify the activities NF-κB/AP-1 signaling pathways. KEY
FINDINGS: TRAF6 high expression in colorectal cancer tissues. And colorectal cancer patients with high expression of TRAF6 had a poor survival rate. TRAF6 knockdown can inhibit proliferation, migration, and invasion of colorectal cancer cells in vitro and in vivo experiments. TRAF6 activates the TRAF6-NF-κB/AP-1 signaling pathway by entering the nucleus, causing biobehavioral changes in colorectal cancer cells. SIGNIFICANCE: TRAF6 plays a vital role in the progression of colorectal cancer. What's more, research elucidating the biological mechanisms of TRAF6 can treated as potential therapeutic target for colorectal cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; NF-kB/c-jun signaling; Nuclear shuttle; TRAF6

Mesh:

Substances:

Year:  2019        PMID: 31487530     DOI: 10.1016/j.lfs.2019.116831

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

1.  The Effects of TRAF6 on Growth and Progression in Colorectal Cancer are Regulated by miRNA-140.

Authors:  Guangwei Zhu; Zhibin Cheng; Chunlin Lin; Qin Wang; Yongjian Huang; Wei Zheng; Shugang Yang; Jianxin Ye
Journal:  Onco Targets Ther       Date:  2020-11-20       Impact factor: 4.147

2.  LOXL1-AS1 contributes to the proliferation and migration of laryngocarcinoma cells through miR-589-5p/TRAF6 axis.

Authors:  Guijun He; Wenfeng Yao; Liang Li; Yang Wu; Guojian Feng; Li Chen
Journal:  Cancer Cell Int       Date:  2020-10-13       Impact factor: 5.722

Review 3.  Strategies for Biomaterial-Based Spinal Cord Injury Repair via the TLR4-NF-κB Signaling Pathway.

Authors:  Bin Lv; Naiting Shen; Zhangrong Cheng; Yuhang Chen; Hua Ding; Jishan Yuan; Kangchen Zhao; Yukun Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-04-29

4.  TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host.

Authors:  Ge Song; Yue Zhang; Jie Tian; Jie Ma; Kai Yin; Huaxi Xu; Shengjun Wang
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 5.  Mechanism by which TRAF6 Participates in the Immune Regulation of Autoimmune Diseases and Cancer.

Authors:  Jingjing Wang; Xinjie Wu; Mengyu Jiang; Guixiang Tai
Journal:  Biomed Res Int       Date:  2020-11-26       Impact factor: 3.411

6.  MiR-452-5p promotes colorectal cancer progression by regulating an ERK/MAPK positive feedback loop.

Authors:  Xin Lin; Lu Han; Chuncai Gu; Yihong Lai; Qiuhua Lai; Qingyuan Li; Chengcheng He; Yan Meng; Lei Pan; Side Liu; Aimin Li
Journal:  Aging (Albany NY)       Date:  2021-03-03       Impact factor: 5.682

7.  TRAF6 regulates the signaling pathway influencing colorectal cancer function through ubiquitination mechanisms.

Authors:  Zhu Guangwei; Cheng Zhibin; Wang Qin; Lin Chunlin; Lin Penghang; He Ruofan; Chen Hui; Robert M Hoffman; Ye Jianxin
Journal:  Cancer Sci       Date:  2022-03-01       Impact factor: 6.716

8.  A Novel Splice Variant of BCAS1 Inhibits β-Arrestin 2 to Promote the Proliferation and Migration of Glioblastoma Cells, and This Effect Was Blocked by Maackiain.

Authors:  Yun-Hua Kuo; Huey-Shan Hung; Chia-Wen Tsai; Shao-Chih Chiu; Shih-Ping Liu; Yu-Ting Chiang; Woei-Cherng Shyu; Shinn-Zong Lin; Ru-Huei Fu
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

9.  Circular RNA GLIS2 promotes colorectal cancer cell motility via activation of the NF-κB pathway.

Authors:  Junxiong Chen; Xiangling Yang; Ruixian Liu; Chuangyu Wen; Huihui Wang; Lanlan Huang; Weiqian Li; Zefeng Zhu; Yonglin Zhu; Huanliang Liu
Journal:  Cell Death Dis       Date:  2020-09-23       Impact factor: 8.469

10.  Combination of autophagy and NFE2L2/NRF2 activation as a treatment approach for neuropathic pain.

Authors:  Jian Li; Mouli Tian; Tong Hua; Haowei Wang; Mei Yang; Wenqian Li; Xiaoping Zhang; Hongbin Yuan
Journal:  Autophagy       Date:  2021-04-09       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.